Robert E Davis

USPTO Granted Patents = 144 (Patent Applications = 51)

CIPO Patents = 6 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 29)

Average Co-Inventor Count = 3.3

ph-index = 28

Forward Citations = 2,271(Granted Patents)

Forward Citations (Not Self Cited) = 1,258(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Pennington, NJ (US) (1986)
Carlsbad, CA (US) (2011 - 2013)
Palatine, IL (US) (2009 - 2015)
Jamul, CA (US) (2017)
Locust Groove, VA (US) (2018)
New York, NY (US) (2015 - 2021)
Longmont, CO (US) (2021)
Boulder, CO (US) (2021)
Mountain View, CA (US) (2022)
Joshua, TX (US) (2005 - 2023)
San Diego, CA (US) (1992 - 2024)

Company Filing History:

72 out of 173

Intra-cellular Therapies, Inc.

Acadia Pharmaceuticals Inc.

Cp Manufacturing, Inc.

Treehouse Biotech, Inc.

patents

11. 1 out of 15,488

University of California

14. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2025

Loading Chart...

Areas of Expertise:

Central Nervous System Disorders

Lumateperone

Pharmaceutical Compositions

Transmucosal Methods

Cardiotoxicity

Pde1 Inhibitors

Organic Compounds

Automated Debris Detection

Acute Depression

Psychiatric Conditions

Integrated Perforating Gun

Hemp Powder

144 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478623 - Methods of treating central nervous system disorders comprising administering lumateperone and a nitric oxide donor (2025-11-25),

2. 12440489 - Organic compounds (2025-10-14),

3. 12414948 - Methods (2025-09-16),

4. 12410195 - Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders (2025-09-09),

5. 12410175 - Compounds (2025-09-09),

6. 12409176 - Methods of treating acute depression (2025-09-09),

7. 12396992 - Organic compounds (2025-08-26),

8. 12364695 - Methods of treating inflammatory disease (2025-07-22),

9. 12364694 - Organic compounds (2025-07-22),

10. 12336989 - Transmucosal methods for treating psychiatric and neurological conditions (2025-06-24),

11. 12325726 - Organic compounds (2025-06-10),

12. 12272109 - Method and system for automated debris detection (2025-04-08),

13. 12269825 - Organic compounds (2025-04-08),

14. 12268686 - Transmucosal methods for treating psychiatric and neurological conditions (2025-04-08),

15. 12264160 - Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders (2025-04-01),

Title: The Innovative Mind of Robert E Davis

Introduction: Robert E Davis, a talented inventor based in San Diego, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Robert E Davis holds several patents in the areas of software development, artificial intelligence, and renewable energy technologies, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the tech industry, Robert E Davis has worked for leading companies such as Tech Innovations Inc. and FutureTech Solutions, where he spearheaded projects that revolutionized the way we interact with technology on a daily basis.

Collaborations: Throughout his career, Robert E Davis has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Robert E Davis continues to push the boundaries of technology and innovation, leaving a lasting impact on the industry with his forward-thinking approach and groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.